ArticleScientific reports2026
Predictors for pediatric bronchitis obliterans in Mycoplasma pneumoniae pneumonia with bronchial casts.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Bronchitis obliterans is a major complication of Mycoplasma pneumoniae pneumonia (MPP) with bronchial casts. This retrospective study aimed to identify predictors of pediatric bronchitis obliterans (PBO) in patients with mycoplasma pneumoniae pneumonia (MPP) complicated by bronchial casts. We screened 236 hospitalized children with MPP and bronchial casts on bronchoscopy between June 2018 and June 2023, of whom 197 were included in the analysis, including 49 with PBO and 148 without PBO. The clinical features, laboratory data, radiological findings, and bronchoscopic features of the children in the PBO and non-PBO groups were compared. Children in the PBO group had a significantly higher incidence of pleural effusion, more severe radiological abnormalities, and higher C-reactive protein level, white blood cell count, erythrocyte sedimentation rate (ESR), and immunoglobulin M level than those in non-PBO group. Additionally, children in the PBO group were more likely to have delayed bronchoscopy (> 13.5 days). Multivariable logistic regression analysis revealed that ESR > 57.5 mm/h (OR: 3.833, P = 0.001), pulmonary consolidation > 2/3 of a lobe (OR: 2.453, P = 0.036) and delayed bronchoscopy (OR 5.827, P < 0.001) were significant predictors of PBO in patients with MPP complicated by bronchial casts.These three indicators combined had a sensitivity of 0.571, specificity of 0.885, and area under the curve of 0.766 for predicting PBO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.